Connection
David Mery to Immunotherapy, Adoptive
This is a "connection" page, showing publications David Mery has written about Immunotherapy, Adoptive.
|
|
Connection Strength |
|
|
|
|
|
0.051 |
|
|
|
-
Sun F, Cheng Y, Chen JR, Wanchai V, Mery DE, Xu H, Gai D, Al Hadidi S, Schinke C, Thanendrarajan S, Zangari M, van Rhee F, Tricot G, Shaughnessy JD, Zhan F. BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions. J Clin Invest. 2024 Jan 02; 134(1).
Score: 0.051